SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma

References

• Starr R, Willson T A, Viney E M, et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917–921
   PubMed Web of Science ®Google Scholar
• Johnston J A. Are SOCS suppressors, regulators, and degraders?. J Leukoc Biol 2004; 75: 743–748
   PubMed Web of Science ®Google Scholar
• To K F, Chan M W, Leung W K, et al. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer 2004; 91: 1335–1341
   PubMed Web of Science ®Google Scholar
• Komazaki T, Nagai H, Emi M, et al. Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers. Jpn J Clin Oncol 2004; 34: 191–194
   PubMed Web of Science ®Google Scholar
• Weniger M A, Melzner I, Menz C K, et al. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 2006; 25: 2679–2684
   PubMed Web of Science ®Google Scholar
• Galm O, Yoshikawa H, Esteller M, et al. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 2003; 101: 2784–2788
   PubMed Web of Science ®Google Scholar
• Komyod W, Bohm M, Metze D, et al. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line. Mol Cancer Res 2007; 5: 271–281
   PubMed Web of Science ®Google Scholar
• Weber A, Hengge U R, Bardenheuer W, et al. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 2005; 24: 6699–6708
   PubMed Web of Science ®Google Scholar
• Oshimo Y, Kuraoka K, Nakayama H, et al. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int J Cancer 2004; 112: 1003–1009
   PubMed Web of Science ®Google Scholar
• Watanabe D, Ezoe S, Fujimoto M, et al. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines. Br J Haematol 2004; 126: 726–735
   PubMed Web of Science ®Google Scholar
• He B, You L, Uematsu K, et al. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci USA 2003; 100: 14133–14138
   PubMed Web of Science ®Google Scholar
• Niwa Y, Kanda H, Shikauchi Y, et al. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 2005; 24: 6406–1617
   PubMed Web of Science ®Google Scholar
• Sutherland K D, Lindeman G J, Choong D Y, et al. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene 2004; 23: 7726–7733
   PubMed Web of Science ®Google Scholar
• Yoshikawa H, Matsubara K, Qian G S, et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001; 28: 29–35
   PubMed Web of Science ®Google Scholar
• Nagai H, Kim Y S, Konishi N, et al. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas. Cancer Lett 2002; 186: 59–65
   PubMed Web of Science ®Google Scholar
• Okochi O, Hibi K, Sakai M, et al. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Clin Cancer Res 2003; 9: 5295–5298
   PubMed Web of Science ®Google Scholar
• Liu W J, Wang L, Wang J P, et al. Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma. Ai Zheng 2006; 25: 696–700
   PubMedGoogle Scholar
• Li Z, Metze D, Nashan D, et al. Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma. J Invest Dermatol 2004; 123: 737–745
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J, Jimenez-Velasco A, Castillejo J A, et al. The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-alpha. Haematologica 2004; 89: 42–48
   PubMed Web of Science ®Google Scholar
• Raccurt M, Tam S P, Lau P, et al. Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. Br J Cancer 2003; 89: 524–532
   PubMed Web of Science ®Google Scholar
• Brender C, Lovato P, Sommer V H, et al. Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia 2005; 19: 209–213
   PubMed Web of Science ®Google Scholar
• Hirohashi S, Ishak K G, Kojiro M, . Hepatocellular carcinoma. WHO Classification of Tumors. Pathology and Genetics. Tumors of the Digestive System, S R Hamilton, L A Aaltonen, et al. IARC, Lyon 2000; 159–180
   Google Scholar
• Feng D Y, Zheng H, Tan Y, et al. Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. World J Gastroenterol 2001; 7: 33–36
   PubMed Web of Science ®Google Scholar
• Yang S F, Wang S N, Wu C F, et al. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumor microvessel density in hepatocellular carcinoma. J Clin Pathol 2007; 60: 642–648
   PubMed Web of Science ®Google Scholar
• Naka T, Narazaki M, Hirata M, et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387: 924–929
   PubMed Web of Science ®Google Scholar
• Auernhammer C J, Bousquet C, Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA 1999; 96: 6964–6969
   PubMed Web of Science ®Google Scholar
• Hilton D J. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999; 55: 1568–1577
   PubMed Web of Science ®Google Scholar
• Siewert E, Muller-Esterl W, Starr R, et al. Different protein turnover of interleukin-6-type cytokine signaling components. Eur J Biochem 1999; 265: 251–257
   PubMedGoogle Scholar
• Sakai I, Takeuchi K, Yamauchi H, et al. Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells. Blood 2002; 100: 2926–2931
   PubMed Web of Science ®Google Scholar
• Lo A K, Lo K W, Tsao S W, et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 2006; 8: 173–180
   PubMed Web of Science ®Google Scholar
• Ogata H, Kobayashi T, Chinen T, et al. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 2006; 131: 179–193
   PubMed Web of Science ®Google Scholar
• Ogata H, Chinen T, Yoshida T, et al. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 2006; 25: 2520–2530
   PubMed Web of Science ®Google Scholar
• Song M M, Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 1998; 273: 35056–35062
   PubMed Web of Science ®Google Scholar
• Harvat B L, Jetten A M. Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ 1996; 7: 289–300
   PubMedGoogle Scholar
• Zhu H, Nelson D R, Crawford J M, et al. Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance. J Interferon Cytokine Res 2005; 25: 528–539
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Yoshida T, Harada M, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165: 1499–1508
   PubMed Web of Science ®Google Scholar